Inogen Inc is an American biotechnology company based in Goleta, California. The firm’s primary focus is on the development and manufacture of portable oxygen concentrators (POCs) that are used by patients suffering from chronic respiratory conditions. The firm’s portable devices, designed for in-home use and travel use, provide supplemental long-term oxygen therapy to patients, restoring quality of life and enabling increased mobility. The firm has been in operation since 2001 and serves a global customer base.
The company markets its POCs both direct to consumers and to Home Medical Equipment (HME) providers. The products are quiet, small and lightweight, unobtrusive, and easy to transport. The company’s Intelligent Delivery Technology ensures that oxygen is delivered in response to the patient’s breathing signals. Inogen devices are also designed as all-in-one stationary or portable devices, reducing the need to frequently deliver cylinder refills, making them a preferred choice of many HMEs.
Inogen Inc describes its products as a single solution for home, ambulatory, travel, and nocturnal treatment. Since launching as a public company in 2004, the firm has traded on the NASDAQ under the stock ticker INGN.
Add INGN stock to your eToro watchlist to keep up to date with daily price movements.